Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Does baricitinib reduce mortality and disease progression in SARS-CoV-2 virus infected patients? A systematic review and meta analysis

Respiratory Medicine(2022)10.1016/j.rmed.2022.106986Source: DataRank Database

Does baricitinib reduce mortality and disease progression in SARS-CoV-2 virus infected patients? A systematic review and meta analysis is a research paper published in Respiratory Medicine (2022). On theSindex it has a DataRank of 0. It has been cited 12 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access12 citations

Download PDF

Cite:

Linked data & code

nct

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Impact (FWCI 0.63)OA: bronzeTopics (28)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (2)

Lee Ying Ying,Sivananthan Manoharan ORCID

Live enrichment

PubMed:36150282 PMC:PMC9477792 OpenAlex:https://openalex.org/W4296205149

FWCI

0.63

Citation Percentile

0.6%

Citation Trend

2022

2023

2024

2025

2026

bronzeLicense: http://www.elsevier.com/open-access/userlicense/1.0/

journalhttp://www.resmedjournal.com/article/S0954611122002517/pdf

publisherhttp://www.resmedjournal.com/article/S0954611122002517/pdf

publisherhttps://api.elsevier.com/content/article/PII:S0954611122002517?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S0954611122002517?httpAccept=text/plain

journalhttps://doi.org/10.1016/j.rmed.2022.106986

Fields of Study

COVID-19 Clinical Research StudiesDiverse Scientific Research StudiesSARS-CoV-2 and COVID-19 Research

MeSH Terms

SARS-CoV-2COVID-19 Drug TreatmentAzetidinesHumansPurinesPyrazolesSulfonamidesDisease Progression

Keywords

MedicineMeta-analysisRelative riskInternal medicineRandomized controlled trialMEDLINERandom effects modelConfidence intervalPublication biasCoronavirus disease 2019 (COVID-19)Subgroup analysisDiseaseMortalitySystematic reviewDisease ProgressionBaricitinibCovid-19

Sustainable Development Goals

SDG 0: Good health and well-being

Does baricitinib reduce mortality and disease progression in SARS-CoV-2 virus infected patients? A systematic review and meta analysis

FAIR Checklist

Authors (2)

Impact

Open Access

Topics

Annotations (Europe PMC)